Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.
Clinical trial NCT03993288 · COMPLETED
Trial details
- NCT number
- NCT03993288
- Sponsor
- Sandoz
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-27
- Primary completion
- 2020-06-18
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.